Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarlowe Regulatory News (MRL)

Share Price Information for Marlowe (MRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 508.00
Bid: 506.00
Ask: 510.00
Change: 0.00 (0.00%)
Spread: 4.00 (0.791%)
Open: 508.00
High: 508.00
Low: 508.00
Prev. Close: 508.00
MRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding and Total Voting Rights

28 Mar 2024 07:00

RNS Number : 6001I
Marlowe PLC
28 March 2024
 

28 March 2024

 

Marlowe plc

 

Director/PDMR Shareholding

 

Total Voting Rights

 

Marlowe plc ("Marlowe", the "Group" or the "Company"), the UK leader in business-critical services and software which assure regulatory compliance, announces that on 27 March 2024, Kevin Quinn, Marlowe's Chairman, exercised 3,913 share options awarded pursuant to the Marlowe 2020 SAYE Scheme at an exercise price of 460 pence per new ordinary share (the "Exercise").

Following the allotment of the new ordinary shares of 50 pence each in the capital of the Company ("Ordinary Shares") to satisfy the Exercise, the Company's issued ordinary share capital will comprise 96,811,631 Ordinary Shares, none of which are held in treasury. Therefore, the total number of Ordinary Shares with voting rights in Marlowe following admission will be 96,811,631.

 

The above figure of 96,811,631 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

The notification below, provided in accordance with the UK Market Abuse Regulation, provides further details.

 

For further information:

 

Marlowe plc

Alex Dacre, Chief Executive

www.marloweplc.com

Adam Councell, Chief Financial Officer

Tel: +44 (0) 203 813 8498

Benjamin Tucker, Head of Investor Relations

Cavendish Capital Markets (Nominated Adviser and Joint Broker)

Ben Jeynes

Tel: +44 (0)20 7220 0500

George Lawson

Berenberg (Joint Broker)

Dan Gee-Summons

Tel: +44 (0)20 3207 7800

Mark Whitmore

Stifel (Joint Broker)

Matthew Blawat

Tel: +44 (0)20 7710 7688

Francis North

FTI Consulting

Nick Hasell

Tel: +44 (0)20 3727 1340

Alex Le May

 

About Marlowe plc

 

Marlowe is a UK leader in business-critical services and software which assure regulatory compliance. The company was formed to create sustainable shareholder value through the acquisition and development of businesses that provide regulated safety and compliance services and software. It is focused on compliance software, eLearning, health & safety, employment law & HR compliance, fire safety & security, water & air hygiene and occupational health services - all of which are vital to the wellbeing of its customers operations and are invariably governed by regulation. Marlowe currently provides software to over 1 million users and services to over 25% of Britain's commercial premises. The Group provides customers with a single outsourced, nationwide, provider of a range of regulated compliance and safety solutions. Our customers can be found in office complexes, high streets & leisure facilities, manufacturing plants and industrial estates, and include thousands of SMEs, local authorities, facilities management providers, multi-site NHS trusts and FTSE 100 companies.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Kevin Quinn

2

Reason for the notification

a)

Position/status

Non-Executive Chairman

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Marlowe plc

b)

LEI

213800ZWSR4SBOM6B608

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 50 pence each

Identification code

ISIN: GB00BD8SLV43

b)

Nature of the transaction

Exercise of share options under the Marlowe 2020 SAYE Scheme

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

460 pence

 

3,913

d)

 

Aggregated information

 N/A single transaction

- Aggregated volume

- Price

e)

Date of the transaction

27 March 2024

 

f)

Place of the transaction

Outside of a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUBSKRSKUOUAR
Date   Source Headline
24th Dec 201910:56 amRNSDirector/PDMR Shareholding
9th Dec 201911:25 amRNSHolding(s) in Company
3rd Dec 20197:00 amRNSAcquisition of Law At Work (Holdings) Limited
3rd Dec 20197:00 amRNSHalf Year Results FY 2020
2nd Dec 20197:00 amRNSAcquisition of FSE Fire Safety Systems Limited
18th Sep 20194:26 pmRNSDirector/PDMR Shareholding
18th Sep 20194:14 pmRNSResult of AGM
3rd Sep 20193:50 pmRNSDirector/PDMR Shareholding
12th Aug 20197:00 amRNSAcquisition of Quantum Compliance
24th Jun 20191:39 pmRNSDirector/PDMR Shareholding
19th Jun 20193:36 pmRNSGrant of Share Options
18th Jun 20197:00 amRNSFinal Results
7th Jun 201911:21 amRNSResult of General Meeting
22nd May 20197:02 amRNSIssue of Equity
22nd May 20197:00 amRNSResults of the Placing
21st May 20194:36 pmRNSAcquisition and Proposed Placing
29th Apr 20197:00 amRNSTrading Update
10th Apr 20197:00 amRNSAppointment of Joint Broker
31st Jan 20197:00 amRNSAcquisition of Atana Limited
21st Jan 20197:00 amRNSDisposal of non-core assets
16th Jan 20193:36 pmRNSDirector/PDMR Shareholding
21st Dec 20187:00 amRNSAcquisition of William Martin
18th Dec 20182:15 pmRNSHolding(s) in Company
4th Dec 20187:01 amRNSHalf Year Results FY 2019
4th Dec 20187:00 amRNSAppointment of Chairman Designate
23rd Nov 20187:00 amRNSNew debt facility
22nd Oct 20187:00 amRNSAcquisition of Firecrest Services Limited
4th Oct 20187:00 amRNSAcquisition of Tersus Consultancy Limited
5th Sep 201810:46 amRNSResult of AGM
28th Aug 20187:00 amRNSAcquisition of Suez WCS Limited
30th Jul 20187:00 amRNSAcquisition of Kingfisher Environmental Services
16th Jul 201810:04 amRNSHolding(s) in Company
13th Jul 20187:00 amRNSPlacing to raise £20 million
25th Jun 20187:00 amRNSFinal Results
18th May 201812:30 pmRNSAcquisition of Forest Environmental
24th Apr 20187:00 amRNSAcquisition of Island Fire Protection Limited
27th Mar 20187:00 amRNSAcquisition of Flamefast Fire Systems Limited
8th Feb 20187:00 amRNSAcquisition of Future Water Limited
12th Jan 20189:37 amRNSHolding(s) in Company
9th Jan 20187:00 amRNSHolding(s) in Company
5th Jan 20189:19 amRNSIssue of Equity
21st Dec 20177:00 amRNSAcquisition of Guardian Water Treatment Limited
11th Dec 20177:00 amRNSHalf-year Report
11th Dec 20177:00 amRNSAppointment of Group Finance Director
26th Oct 20177:00 amRNSAcquisition
24th Oct 20174:45 pmRNSHolding(s) in Company
20th Oct 20177:00 amRNSHalf Year Trading Update
13th Oct 20174:50 pmRNSHolding(s) in Company
20th Sep 20176:15 pmRNSHolding(s) in Company
19th Sep 201710:55 amRNSResult of AGM Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.